Literature DB >> 1349561

Genotype mosaicism in fragile X fetal tissues.

D Wöhrle1, M C Hirst, I Kennerknecht, K E Davies, P Steinbach.   

Abstract

The fragile X syndrome is one of the most common familial causes of mental retardation. It is associated with the expression of a fragile site at Xq27.3, although not all individuals carrying the mutation are fragile-X-positive. Recently, the mutation causing this disease has been identified as the amplification of, or insertion into, a CGG repeat sequence at the fragile site. The mutated chromosome can be recognised by the decrease in mobility of the EcoRI fragment that covers the mutated region. Analysis of lymphocytes of affected males often gives a number of different sized fragments indicating somatic heterogeneity. We have investigated this mosaicism in various tissues of an affected fetus in order to determine the extent of the variation between tissues, and to ascertain how to interpret the results in lymphocytes. Our results suggest that the heterogeneity occurs in all fetal tissues, but that the pattern of fragments observed varies between tissues. Methylation across the region also varies. These differences may be reflected in the cellular phenotypes and may influence the ultimate expression of the clinical phenotype.

Entities:  

Mesh:

Year:  1992        PMID: 1349561     DOI: 10.1007/bf00207057

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.

Authors:  I Oberlé; F Rousseau; D Heitz; C Kretz; D Devys; A Hanauer; J Boué; M F Bertheas; J L Mandel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

2.  Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n.

Authors:  E J Kremer; M Pritchard; M Lynch; S Yu; K Holman; E Baker; S T Warren; D Schlessinger; G R Sutherland; R I Richards
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

3.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium.

Authors:  G R Sutherland
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

4.  Fragile X expression and X inactivation. I. The expression of the fragile site at Xq27.3 is not suppressed on inactive X chromosomes separated from the active homologue.

Authors:  D Wöhrle; J P Fryns; P Steinbach
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

5.  The marker (X) syndrome: a cytogenetic and genetic analysis.

Authors:  S L Sherman; N E Morton; P A Jacobs; G Turner
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

6.  Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis.

Authors:  A Vincent; D Heitz; C Petit; C Kretz; I Oberlé; J L Mandel
Journal:  Nature       Date:  1991-02-14       Impact factor: 49.962

7.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Genotype prediction in the fragile X syndrome.

Authors:  M C Hirst; Y Nakahori; S J Knight; C Schwartz; S N Thibodeau; A Roche; T J Flint; J M Connor; J P Fryns; K E Davies
Journal:  J Med Genet       Date:  1991-12       Impact factor: 6.318

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome.

Authors:  M V Bell; M C Hirst; Y Nakahori; R N MacKinnon; A Roche; T J Flint; P A Jacobs; N Tommerup; L Tranebjaerg; U Froster-Iskenius
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  14 in total

1.  Cloned human FMR1 trinucleotide repeats exhibit a length- and orientation-dependent instability suggestive of in vivo lagging strand secondary structure.

Authors:  M C Hirst; P J White
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

2.  Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats.

Authors:  D Wöhrle; U Salat; D Gläser; J Mücke; M Meisel-Stosiek; D Schindler; W Vogel; P Steinbach
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

3.  Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

Authors:  D Wöhrle; U Salat; H Hameister; W Vogel; P Steinbach
Journal:  Am J Hum Genet       Date:  2001-07-13       Impact factor: 11.025

4.  Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism.

Authors:  P J White; R H Borts; M C Hirst
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

6.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

7.  Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm.

Authors:  G Jansen; P Willems; M Coerwinkel; W Nillesen; H Smeets; L Vits; C Höweler; H Brunner; B Wieringa
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

8.  Population dynamics of a meiotic/mitotic expansion model for the fragile X syndrome.

Authors:  A E Ashley; S L Sherman
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

9.  Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.

Authors:  E de Graaff; R Willemsen; N Zhong; C E de Die-Smulders; W T Brown; G Freling; B Oostra
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

10.  Molecular analysis of mutations in the gene FMR-1 segregating in fragile X families.

Authors:  P Steinbach; D Wöhrle; G Tariverdian; I Kennerknecht; G Barbi; H Edlinger; H Enders; M Götz-Sothmann; H Heilbronner; D Hosenfeld
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.